ARC1905 (anti-C5 aptamer) Given With Lucentis 0.5 mg In People With Neovascular Age-Related Macular Degeneration

Trial Identifier: OPH2000
Sponsor: Ophthotech Corporation
Start Date: October 2008
Primary Completion Date: December 2009
Study Completion Date: December 2009
Condition: Macular Degeneration

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
USA, NY New York, NY, USA, 10119